BiotechTube
Home/Pipeline/Biomarker Assays (e.g., DDR, PD-L1)

Biomarker Assays (e.g., DDR, PD-L1)

Oncology

Service/DevelopmentActive

Key Facts

Indication
Oncology
Phase
Service/Development
Status
Active
Company
CelLBxHealth

About CelLBxHealth

CelLBxHealth is a publicly traded, commercial-stage diagnostics company leveraging its proprietary Parsortix microfluidics platform to isolate intact circulating tumor cells from a simple blood draw. Its core business involves selling the Parsortix PC1 system (clinical) and PR1 system (research), complemented by a global GCP-compliant laboratory service offering for pharma and research clients. The company is positioned in the high-growth liquid biopsy market, aiming to enable minimally invasive, repeatable testing for cancer monitoring and research across multiple solid tumor types.

View full company profile

Therapeutic Areas

Oncology

Other Oncology Drugs

DrugCompanyPhase
mRNA Anticancer VaccineSunshine BiopharmaPreclinical Research
Biosimilar BevacizumabOrganon (2)Phase 3
Biosimilar PembrolizumabOrganon (2)Phase 3
BCL-2 Inhibitor ProgramVincerx PharmaPreclinical
Attenukine Oncology CandidateTevaPhase 1
KEAP1 Activator ProgramVividion TherapeuticsPhase 1
Personalized Medicine Assays (Patient-Derived Explants)Aurita BioscienceResearch-Use Only
CDK2-CyclinE1 & CDK2-CyclinA2 AssayAurora BiolabsCommercial
POLQ & eIF4E AssayAurora BiolabsCommercial
PKMYT1 & WEE1 AssayAurora BiolabsCommercial
NTP42ATXA TherapeuticsPreclinical
Athebody® DARPins for pHLA-binding T-Cell EngagersAthebioPre-clinical